Health Portal - Answers, One Place

Government launches fund to boost biotech growth

Government launches fund to boost biotech growth

by Nabila Anuar • 11 hours ago

Panel urges health ministry to study Ayush drug costs

Panel urges health ministry to study Ayush drug costs

by Beatrice Gray • 1 day ago

BMS reports positive Phase II data for relapsed multiple myeloma

BMS reports positive Phase II data for relapsed multiple myeloma

by Beatrice Gray • 2 days ago

Clover’s combo vaccine passes Phase II in seniors

Clover’s combo vaccine passes Phase II in seniors

by Beatrice Gray • 3 days ago

Symptom Checker

Specialist Directory

BMS reports positive Phase II data for relapsed multiple myeloma

Specialist Directory

BMS reports positive Phase II data for relapsed multiple myeloma

by Beatrice Gray • 2 days ago

Clover’s combo vaccine passes Phase II in seniors

Specialist Directory

Clover’s combo vaccine passes Phase II in seniors

by Beatrice Gray • 3 days ago

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Specialist Directory

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

by Beatrice Gray • 4 days ago

First patient receives BHB810 in BigHat study

Specialist Directory

First patient receives BHB810 in BigHat study

by Nabila Anuar • Sep 2, 2026

MOST READ

Government launches fund to boost biotech growth

Symptom Checker

Government launches fund to boost biotech growth

Nabila Anuar • 11 hours ago

Panel urges health ministry to study Ayush drug costs

Panel urges health ministry to study Ayush drug costs

1 day ago

Arlo points to promising Phase II data for swelling disorder drug

Arlo points to promising Phase II data for swelling disorder drug

6 days ago

Jazz reports interim Phase III results for Ziihera

Jazz reports interim Phase III results for Ziihera

Sep 1, 2026

BMS reports positive Phase II data for relapsed multiple myeloma

Specialist Directory

BMS reports positive Phase II data for relapsed multiple myeloma

Beatrice Gray • 2 days ago

Clover’s combo vaccine passes Phase II in seniors

Clover’s combo vaccine passes Phase II in seniors

3 days ago

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

4 days ago

First patient receives BHB810 in BigHat study

First patient receives BHB810 in BigHat study

Sep 2, 2026

Sensorion Wins Approval for HearConnex Trial in France

Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

Rina Raha • Sep 4, 2026

Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings

Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings

Aug 31, 2026

Ocugen starts trial of new eye treatment

Ocugen starts trial of new eye treatment

Nabila Anuar • Sep 3, 2026

HiRO partners with Differentia Biotech for trial simulation

HiRO partners with Differentia Biotech for trial simulation

Aug 31, 2026

Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • Sep 4, 2026

Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings

Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings

by Rina Raha • Aug 31, 2026

Lab Explainers

Ocugen starts trial of new eye treatment

by Nabila Anuar • Sep 3, 2026

Ocugen starts trial of new eye treatment

HiRO partners with Differentia Biotech for trial simulation

by Beatrice Gray • Aug 31, 2026

HiRO partners with Differentia Biotech for trial simulation

BETTER LIVING

Clover’s combo vaccine passes Phase II in seniors

Clover’s combo vaccine passes Phase II in seniors

By Beatrice Gray • 3 days ago

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

By Beatrice Gray • 4 days ago

Arlo points to promising Phase II data for swelling disorder drug

Arlo points to promising Phase II data for swelling disorder drug

By Nabila Anuar • 6 days ago

ALL POST

Government launches fund to boost biotech growth

Symptom Checker

Government launches fund to boost biotech growth

by Nabila Anuar • 11 hours ago

Panel urges health ministry to study Ayush drug costs

Symptom Checker

Panel urges health ministry to study Ayush drug costs

by Beatrice Gray • 1 day ago

BMS reports positive Phase II data for relapsed multiple myeloma

Specialist Directory

BMS reports positive Phase II data for relapsed multiple myeloma

by Beatrice Gray • 2 days ago

Clover’s combo vaccine passes Phase II in seniors

Specialist Directory

Clover’s combo vaccine passes Phase II in seniors

by Beatrice Gray • 3 days ago

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Specialist Directory

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

by Beatrice Gray • 4 days ago

Arlo points to promising Phase II data for swelling disorder drug

Symptom Checker

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 6 days ago

Sensorion Wins Approval for HearConnex Trial in France

Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • Sep 4, 2026

Ocugen starts trial of new eye treatment

Ocugen starts trial of new eye treatment

by Nabila Anuar • Sep 3, 2026

First patient receives BHB810 in BigHat study

Specialist Directory

First patient receives BHB810 in BigHat study

by Nabila Anuar • Sep 2, 2026

Jazz reports interim Phase III results for Ziihera

Symptom Checker

Jazz reports interim Phase III results for Ziihera

by Nabila Anuar • Sep 1, 2026